Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South Africa;Occasions perdues d'achever les tests de lymphocyte CD4+ parmi les patients séropositifs au VIH en Afrique du Sud

Bulletin of the World Health Organization

Volumn 88, Issue 9, 2010, Pages 675-680

  Larson, Bruce A ^a   Brennan, Alana ^a   McNamara, Lynne ^b   Long, Lawrence ^b   Rosen, Sydney ^a   Sanne, Ian ^b   Fox, Matthew P ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

DISEASE TREATMENT; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; INFORMATION SYSTEM; REGRESSION ANALYSIS; TESTING METHOD;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; EMPLOYMENT STATUS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COUNSELING; PREDICTION; SEX DIFFERENCE; SOUTH AFRICA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTH AFRICA; TIME FACTORS; WORLD HEALTH ORGANIZATION;

SOUTH AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 77956902293     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.09.068981     Document Type: Article

References (22)

1. South African National Department of Health. HIV and AIDS and STI Strategic Plan for South Africa, 2007-2011. Johannesburg: Department of Health; 2007. Available from: http://www.doh.gov.za/docs/misc/stratplan-f.html [accessed 17 March 2010].
2. Fairall LR, Bachmann M. Effectiveness of antiretroviral treatment in a South African program. Arch Intern Med 2008;168:86-93. doi:10.1001/archinternmed.2007.10 PMID:18195200
3. Rosen S, Long L, Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health 2008;13:1005-1015. doi:10.1111/j.1365-3156.2008.02114.x PMID:18631314
4. Centers for Disease Control and Prevention. Revised guidelines for HIV counseling, testing, and referral and revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep 2001;50(No. RR-19):1-81. PMID:11215787
5. Lawn SD, Little F, Bekker L-G, Kaplan R, Campbel E, Orrell C, Wood R. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009;23:335-342. doi:10.1097/QAD.0b013e328321823f PMID:19114870
6. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008;22:1897-1908. doi:10.1097/QAD.0b013e32830007cd PMID:18784453
7. Bartlett JG. Update on opt-out testing and initial antiretroviral therapy - CROI 2007. Medscape HIV/AIDS 2007.
8. Robbins G, Chan E, Spritzler J, Asmuth D, Gandhi R, Rodriguez B, et al. Effect of baseline CD4 cell count on immune reconstitution during combination antiretroviral therapy in ACTG 384. Presented at the: Fourth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, Sydney,Australia, 22-25 July 2007.
9. Shisana O, Rehle T, Simbayi L, Zuma Z, Jooste J, Pillay-van-Wyk V, et al. South African national prevalence, incidence, behaviour and communication survey, 2008: a turning tide among teenagers? Cape Town: HSRC Press; 2009.
10. UNAIDS/WHO policy statement on HIV testing. Geneva: United Nations Joint Programme on HIV/AIDS, World Health Organization; 2004.
11. April MD, Walensky RP, Chang Y, Pitt J, Freedberg KA, Losina E etal. HIV Testing Rates and Outcomes in a South African Community, 2001-2006: Implications for Expanded Screening Policies. J Acquir Immune Defic Syndr 2009;51:310-316. doi:10.1097/QAI.0b013e3181a248e6 PMID:19582895
12. Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J etal. Loss to Care and Death Before Antiretroviral Therapy in Durban, South Africa. J Acquir Immune Defic Syndr 2009;51:135-139. doi:10.1097/QAI.0b013e3181a44ef2 PMID:19504725
13. Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, et al. The "ART" of linkage: early loss to follow up (LTFU) after HIV diagnosis at two PEPFAR sites in Durban, South Africa (Poster TUPE0345). Presented at the: XVIIth International AIDS Conference, Mexico City, Mexico, 3-8 August 2008.
14. Micek MA, Gimbel-Sherr K, Baptista AJ, Matediana E, Montoya P, Pfeiffer J etal. Loss to follow-up of adults in public HIV care systems in central Mozambique: identifying obstacles to treatment. JAIDS 2009;52:397-405. PMID:19550350
15. Nsigaye R, Wringe A, Roura M, Kalluvya S, Urassa M, Busza J etal. From HIV diagnosis to treatment: evaluation of a referral system to promote and monitor access to antiretroviral therapy in rural Tanzania. J Int AIDS Soc 2009;12:31. doi:10.1186/1758-2652-12-31 PMID:19906291
16. Jones PS. On a never-ending waiting list: toward equitable access to anti-retroviral treatment? Experiences from Zambia. Health Hum Rights 2005;8:76-102. doi:10.2307/4065335 PMID:17136904
17. Horne R, Cooper V, Gellaitry G, Date H, Fisher M. Patients' perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: the utility of the necessity-concerns framework. J Acquir Immune Defic Syndr 2007;45:334-341. PMID:17514019
18. Kinsler JJ, Wong M, Sayles J, Davis C, Cunningham W. The effect of perceived stigma from a health care provider on access to care among a low-income HIV-positive population. AIDS Patient Care STDS 2007;21:584-592. doi:10.1089/apc.2006.0202 PMID:17711383
19. Mshana GH, Wamoyi J, Busza J, Zaba B, Changalucha J, Kaluvya S. etal. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program AIDS Patient Care STDS 2006;20:649-657. doi:10.1089/apc.2006.20.649 PMID:16987051
20. Wilson DP, Blower S. How far will we need to go to reach HIV-infected people in rural South Africa? BMC Med 2007;5:16. doi:10.1186/1741-7015-5-16 PMID:17577418
21. Makombe SD, Jahn A, Tweya H, Chuka S, Yu JK, Hochgesang M etal. A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS ONE 2007;2:e620. doi:10.1371/journal.pone.0000620 PMID:17637836
22. Muula AS, Ngulube T, Siziya S, Makupe C, Umar E, Prozesky H etal. Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review. BMC Public Health 2007;7:63. doi:10.1186/1471-2458-7-63 PMID:17459154